novartis, australia & new zealand

Novartis is improving the lives of more than 2.5 million patients across Australia and New Zealand through our medicines. By partnering with the healthcare system we are working for patients to address their needs, and we are committed to accelerating patient access to life saving treatments and associated healthcare. We are reimagining medicine by using innovative science and technology to address challenging healthcare issues and our rich research pipeline has 50+ ongoing Phase III programs. We are transforming how clinical trials are run to increase patients’ access to our industry-leading clinical trials footprint in Australia. We continue to work on improving our environment for diversity, equity and inclusion and being a family friendly employer. Every day our inspired, curious, unbossed, and integrity-driven culture unites our people and encourages leadership at every level. See our community guidelines here: https://bit.ly/2meXCdH Novartis is aware of employment scams which make false use of our company name or leader’s names to defraud job seekers. Novartis does not make job offers without interview and never asks candidates for money. All our current job openings are displayed here and on our novartis.com.au website. If you have encountered a job posting or been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond, send money or personal information.

George Clinical

George Clinical is a leading global clinical research organization founded in Asia-Pacific driven by scientific expertise and operational excellence. With over 20 years of experience and more than 500 people managing 40 geographical locations throughout the Asia-Pacific region, USA and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials. Stay up to date on the latest clinical research news, case studies and perspectives from George Clinical thought leaders by signing up for our monthly e-newsletter. georgeclinical.com/subscribe/newsletter

PharmaCare Laboratories

PharmaCare is one of the largest Australian-owned health, wellness and consumer goods companies in the country. An Australian-born and built success story, PharmaCare is dedicated to enriching people’s lives through improved health and wellness. Despite its products being available globally, its soul is Australian, its quality is Australian, and its spirit of honesty, hard work and entrepreneurial drive is Australian. PharmaCare’s trusted, household brands include Sambucol, Nature’s Way, Bioglan, Medi+, Ease-a-Cold, Skin Doctors, KP24, Brut, Norsca, Bounce and many more. Our global wheelhouse of brands is available in 40 countries, over 5,200 pharmacies, 3,000 supermarkets, plus department and variety stores all over Australia, New Zealand, Asia, The America's and Europe.

GMP Pharmaceuticals Ltd

GMP Pharmaceuticals is one of the leading multi-national pharmaceutical manufacturers specializing in a wide range of complementary medicines, natural health products & Infant Formulas of Australia and New Zealand origin. Our modern plants,spreading over 80,000 square meter of land with about 40000 square meter building floor size in Sydney and Auckland,have been specifically designed to have the capacity to manufacture most natural foods, dietary supplements, infant formula and nutritional powder available. GMP Pharmaceuticals has been servicing the health food industries worldwide since 1994 with a comprehensive range of dosage forms and packaging options. GMP Dairy plant, located in Auckland, is currently the only GMP certified pharmaceuticals standard infant formula plant in Australasia. Both GMP Pharmaceuticals plants, located in Sydney & Auckland, are certified and licensed by The Australian and New Zealand Government’s as well as world bodies to manufacture: Complementary medicines, dietary supplements, restricted animal products, baby nutrition , organic foods, halal certified products and more, please call or email our office to see how we can be of service to you.

Shionogi Inc. (U.S.)

Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide.